Paper Linking Vaccine to Behavioral Changes Removed

The editor in chief of Vaccine has “temporarily removed” a study, published on the journal’s website in January, which suggested the aluminum adjuvant in an HPV vaccine caused behavioral changes in mice.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NCIA paper claiming to report a link between behavioral changes in mice and the aluminum adjuvant in a vaccine against human papillomavirus (HPV) has been temporarily removed from the website of the journal that published it a month ago, according to Retraction Watch. The paper, “Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil,” was appeared online in Vaccine January 9. But now, the page that used to display the paper’s abstract has been replaced by a message that reads: “The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated.”

Two of the paper’s coauthors—Christopher Shaw of the University of British Columbia and Lucija Tomljenovic of the University of British Columbia and the Sheba Medical Center in Ramat Gan, Israel—published a 2011 study suggesting a link between aluminum adjuvants in vaccines and autism. Those findings were criticized by the World Health Organization (WHO), which called the work “seriously flawed,” according to Retraction Watch.

One of the Vaccine paper’s coauthors, Yehuda Shoenfeld of Tel Aviv University, forwarded Retraction Watch an email he sent to the journal upon learning that the paper was temporarily removed. “This morning we tried to access it through PubMed and we found that there has been a TEMPORARY REMOVAL,” the email read. “We will like to know the reason or if this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo